Disruption of [Ca2+]cyt homeostasis induced by the enhanced Ca2+ entry mode of NCX1 has been detected in several cancer, such as pancreatic cancer [36], breast cancer [37], glioblastoma [38], and melanoma [39]. This evidence concerns the gene SLC8A1 and breast cancer.